Published in Annu Rev Biochem on January 01, 2009
The hallmarks of aging. Cell (2013) 14.29
Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63
Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol (2010) 3.54
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol (2011) 2.94
Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science (2010) 2.92
Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol Cell (2010) 2.74
Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol (2011) 2.70
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Organizing principles of mammalian nonsense-mediated mRNA decay. Annu Rev Genet (2013) 2.55
Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Mol Cell (2009) 2.47
Local slowdown of translation by nonoptimal codons promotes nascent-chain recognition by SRP in vivo. Nat Struct Mol Biol (2014) 2.43
Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J Cell Biol (2010) 2.32
Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol (2013) 2.24
RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature (2012) 2.11
Cytoplasmic protein quality control degradation mediated by parallel actions of the E3 ubiquitin ligases Ubr1 and San1. Proc Natl Acad Sci U S A (2009) 2.05
CFTR: folding, misfolding and correcting the ΔF508 conformational defect. Trends Mol Med (2011) 1.99
The biology of proteostasis in aging and disease. Annu Rev Biochem (2015) 1.96
The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev (2012) 1.95
Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener (2012) 1.95
Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism. Chem Biol (2011) 1.89
Neurology of inherited glycosylation disorders. Lancet Neurol (2012) 1.82
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature (2012) 1.75
Cellular strategies of protein quality control. Cold Spring Harb Perspect Biol (2011) 1.74
Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr Opin Cell Biol (2011) 1.74
Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener (2009) 1.73
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70
Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci (2011) 1.66
Regulation of organismal proteostasis by transcellular chaperone signaling. Cell (2013) 1.66
Small-molecule proteostasis regulators for protein conformational diseases. Nat Chem Biol (2011) 1.64
Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases. Mol Cell (2014) 1.56
The ribosome as a hub for protein quality control. Mol Cell (2013) 1.53
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease. Chem Biol (2014) 1.52
A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways. Cell (2014) 1.52
Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med (2014) 1.52
Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet (2011) 1.52
Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem (2009) 1.51
Diversity in the origins of proteostasis networks--a driver for protein function in evolution. Nat Rev Mol Cell Biol (2013) 1.51
Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Mol Med (2009) 1.49
The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb Perspect Biol (2011) 1.48
Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol (2010) 1.48
Malfolded protein structure and proteostasis in lung diseases. Am J Respir Crit Care Med (2014) 1.47
Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab (2011) 1.47
The cotranslational function of ribosome-associated Hsp70 in eukaryotic protein homeostasis. Cell (2013) 1.46
SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Res (2011) 1.44
Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. Elife (2013) 1.44
Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis (2010) 1.42
Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis. Cold Spring Harb Perspect Biol (2011) 1.41
Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis. Mol Biol Cell (2010) 1.41
Firefly luciferase mutants as sensors of proteome stress. Nat Methods (2011) 1.35
Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat Rev Rheumatol (2011) 1.34
Systemic amyloidoses. Annu Rev Biochem (2013) 1.34
Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol (2011) 1.33
Protein folding in the cell: challenges and progress. Curr Opin Struct Biol (2010) 1.32
Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci (2013) 1.31
The proteostasis boundary in misfolding diseases of membrane traffic. FEBS Lett (2009) 1.31
A Phos-tag-based approach reveals the extent of physiological endoplasmic reticulum stress. PLoS One (2010) 1.29
Recent advances in our understanding of neurodegeneration. J Neural Transm (Vienna) (2009) 1.27
The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. Gastroenterology (2013) 1.27
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol (2010) 1.26
Dual action of ATP hydrolysis couples lid closure to substrate release into the group II chaperonin chamber. Cell (2011) 1.25
Direct three-dimensional visualization of membrane disruption by amyloid fibrils. Proc Natl Acad Sci U S A (2012) 1.24
Emergent properties of proteostasis in managing cystic fibrosis. Cold Spring Harb Perspect Biol (2011) 1.24
Molecular chaperones and substrate ubiquitination control the efficiency of endoplasmic reticulum-associated degradation. Diabetes Obes Metab (2010) 1.23
Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol Med (2010) 1.22
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Fine-tuning multiprotein complexes using small molecules. ACS Chem Biol (2012) 1.21
Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb Perspect Med (2013) 1.20
A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet (2011) 1.19
Applying Hsp104 to protein-misfolding disorders. Biochem Cell Biol (2010) 1.18
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep (2014) 1.17
Control of substrate gating and translocation into ClpP by channel residues and ClpX binding. J Mol Biol (2010) 1.16
Measurement of protein unfolding/refolding kinetics and structural characterization of hidden intermediates by NMR relaxation dispersion. Proc Natl Acad Sci U S A (2011) 1.15
Mysterious oligomerization of the amyloidogenic proteins. FEBS J (2010) 1.14
Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol (2010) 1.13
Discovery and characterization of a mammalian amyloid disaggregation activity. Protein Sci (2010) 1.13
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci U S A (2012) 1.13
Functional interactions as a survival strategy against abnormal aggregation. FASEB J (2010) 1.13
Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med (2010) 1.13
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis. Mol Biol Cell (2013) 1.13
Protein aggregation caused by aminoglycoside action is prevented by a hydrogen peroxide scavenger. Mol Cell (2012) 1.12
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail (2014) 1.12
Protein homeostasis as a therapeutic target for diseases of protein conformation. Curr Top Med Chem (2012) 1.10
Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones. ACS Chem Biol (2010) 1.08
Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet (2010) 1.08
Cellular strategies for regulating functional and nonfunctional protein aggregation. Cell Rep (2012) 1.08
The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat Cell Biol (2011) 1.08
Disruption of protein quality control in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.07
Cyanoquinolines with independent corrector and potentiator activities restore ΔPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis. Mol Pharmacol (2011) 1.07
Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc Natl Acad Sci U S A (2011) 1.06
Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signaling. Genes Dev (2014) 1.06
Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med (2012) 1.06
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol (2011) 1.06
Emergence and natural selection of drug-resistant prions. Mol Biosyst (2010) 1.05
Role of Hsp90 in biogenesis of the beta-cell ATP-sensitive potassium channel complex. Mol Biol Cell (2010) 1.03
Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT. EMBO J (2010) 1.02
α-Galactosidase aggregation is a determinant of pharmacological chaperone efficacy on Fabry disease mutants. J Biol Chem (2012) 1.02
Regulating the 20S proteasome ubiquitin-independent degradation pathway. Biomolecules (2014) 1.02
A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity. J Am Chem Soc (2010) 1.02
Adapting proteostasis for disease intervention. Science (2008) 13.22
Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science (2010) 11.29
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68
PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature (2007) 6.61
The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell (2011) 6.05
Opposing activities protect against age-onset proteotoxicity. Science (2006) 5.85
Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (2006) 5.39
Semen-derived amyloid fibrils drastically enhance HIV infection. Cell (2007) 5.23
Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem (2008) 5.22
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01
Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science (2009) 4.80
Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63
Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell (2003) 4.63
Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods (2004) 4.62
Therapeutic approaches to protein-misfolding diseases. Nature (2003) 4.57
Functional amyloid--from bacteria to humans. Trends Biochem Sci (2007) 4.50
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 4.25
New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet (2005) 4.18
Functional amyloid formation within mammalian tissue. PLoS Biol (2006) 3.92
ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol (2013) 3.88
Regulation of life-span by germ-line stem cells in Caenorhabditis elegans. Science (2002) 3.85
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology (2012) 3.48
Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science (2007) 3.46
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A (2009) 3.44
Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature (2011) 3.32
Structural basis for cargo regulation of COPII coat assembly. Cell (2008) 3.15
Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell (2008) 3.11
Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem (2005) 2.95
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2004) 2.89
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell (2009) 2.87
The biological and chemical basis for tissue-selective amyloid disease. Cell (2005) 2.76
Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease. Proc Natl Acad Sci U S A (2002) 2.71
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science (2003) 2.63
Structure of the Sec13/31 COPII coat cage. Nature (2006) 2.63
Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science (2008) 2.59
Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci (2002) 2.58
An experimental survey of the transition between two-state and downhill protein folding scenarios. Proc Natl Acad Sci U S A (2008) 2.57
Molecular chaperones and the stress of oncogenesis. Oncogene (2004) 2.51
Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem (2004) 2.45
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics. Nature (2004) 2.44
Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol (2006) 2.37
Structure-function-folding relationship in a WW domain. Proc Natl Acad Sci U S A (2006) 2.28
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A (2012) 2.27
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res (2005) 2.25
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A (2002) 2.25
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants. ACS Chem Biol (2006) 2.25
Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J (2004) 2.24
Polyglutamine protein aggregates are dynamic. Nat Cell Biol (2002) 2.21
XBP-1 is a cell-nonautonomous regulator of stress resistance and longevity. Cell (2013) 2.20
Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol (2006) 2.17
Tuning the free-energy landscape of a WW domain by temperature, mutation, and truncation. Proc Natl Acad Sci U S A (2003) 2.15
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A (2004) 2.14
RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature (2012) 2.11
The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci (2008) 2.10
SMK-1, an essential regulator of DAF-16-mediated longevity. Cell (2006) 2.10
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat Chem Biol (2011) 2.08
Aging as an event of proteostasis collapse. Cold Spring Harb Perspect Biol (2011) 2.06
The biology of proteostasis in aging and disease. Annu Rev Biochem (2015) 1.96
Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem (2006) 1.91
The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol (2006) 1.88
Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep (2013) 1.87
An adaptable standard for protein export from the endoplasmic reticulum. Cell (2007) 1.86
ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol (2003) 1.82
Protein homeostasis and aging in neurodegeneration. J Cell Biol (2010) 1.76
Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. Chem Biol (2004) 1.76
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature (2012) 1.75
Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol (2005) 1.74
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A (2013) 1.73
Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. Mol Cell (2006) 1.71
A conserved ubiquitination pathway determines longevity in response to diet restriction. Nature (2009) 1.71
COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code. J Cell Biol (2004) 1.70
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70
Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell (2008) 1.69
Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Chem Biol (2005) 1.68
Regulation of organismal proteostasis by transcellular chaperone signaling. Cell (2013) 1.66
Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci (2006) 1.65
C. elegans telomeres contain G-strand and C-strand overhangs that are bound by distinct proteins. Cell (2008) 1.65
Small-molecule proteostasis regulators for protein conformational diseases. Nat Chem Biol (2011) 1.64
Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov (2002) 1.63
Geranylgeranyl switching regulates GDI-Rab GTPase recycling. Structure (2003) 1.63
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol (2010) 1.62
Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J (2012) 1.62
Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity. Sci Transl Med (2011) 1.62
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol (2006) 1.60